STRO
Sutro BiopharmaNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$423.71M
P/E Ratio
—
EPS
$-16.35
Beta
1.64
52W High
$43.85
52W Low
$6.74
50-Day MA
$30.32
200-Day MA
$16.31
Dividend Yield
—
Profit Margin
-154.20%
Forward P/E
10.03
PEG Ratio
—
About Sutro Biopharma
Sutro Biopharma, Inc. is a clinical stage drug discovery, development and manufacturing company. The company is headquartered in South San Francisco, California.
Fundamentals
| Revenue (TTM) | $99.61M |
| Gross Profit (TTM) | $-66.81M |
| EBITDA | $-79.84M |
| Operating Margin | -203.90% |
| Return on Equity | -1810.00% |
| Return on Assets | -19.30% |
| Revenue/Share (TTM) | $10.29 |
| Book Value | $-15.43 |
| Price-to-Book | 2.11 |
| Price-to-Sales (TTM) | 4.25 |
| EV/Revenue | 2.332 |
| EV/EBITDA | 41.71 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -16.50% |
| Shares Outstanding | $16.57M |
| Float | $10.51M |
| % Insiders | 2.30% |
| % Institutions | 86.54% |
Historical Volatility
HV 10-Day
104.52%
HV 20-Day
95.89%
HV 30-Day
93.40%
HV 60-Day
82.96%
HV Rank
64.7%
Volatility is currently expanding
Analyst Ratings
Consensus ($46.64 target)
2
Strong Buy8
Buy1
Hold1
Strong SellMore HEALTHCARE Stocks
Data last updated: 5/25/2026